1.A Case of Cervical Chondrocutaneous Branchial Remnant Comprised of Hyaline Cartilage
Sang Jin CHEON ; Tae Wook KIM ; Seong Min PARK ; Hyun Ju LEE ; HyunJu JIN ; Woo Haing SHIM ; Gun Wook KIM ; Hoon Soo KIM ; Hyun Chang KO ; Byung Soo KIM ; Moon Bum KIM ; Hyang Suk YOU
Annals of Dermatology 2019;31(1):101-103
No abstract available.
Hyalin
;
Hyaline Cartilage
2.Does Radiofrequency Ablation Induce Neoplastic Changes in Benign Thyroid Nodules: A Preliminary Study
Su Min HA ; Jun Young SHIN ; Jung Hwan BAEK ; Dong Eun SONG ; Sae Rom CHUNG ; Young Jun CHOI ; Jeong Hyun LEE
Endocrinology and Metabolism 2019;34(2):169-178
BACKGROUND: To evaluate the clinical feasibility of radiofrequency ablation (RFA) of benign thyroid nodules along with cytomorphological alteration, and any malignant transformation through biopsy. METHODS: The data were retrospectively collected between April 2008 and June 2013 and core needle biopsy (CNB) was performed on 16 benign thyroid nodules previously treated using RFA. The parameters of the patients were compared, between the time of enrollment and the last follow-up examination, using linear mixed model statistical analysis. RESULTS: No atypical cells or neoplastic transformation were detected in the undertreated peripheral portion of treated benign nodules on the CNB specimen. RFA altered neither the thyroid capsule nor the thyroid tissue adjacent to the treated area. On histopathological examinations, we observed 81.2% acellular hyalinization, which was the most common finding. After a mean follow-up period of over 5 years, the mean volume of thyroid nodule had decreased to 6.4±4.2 mL, with a reduction rate of 81.3%±5.8% (P<0.0001). CONCLUSION: RFA is a technically feasible treatment method for benign thyroid nodules, with no carcinogenic effect or tissue damage of the normal thyroid tissue adjacent to the RFA-treated zone.
Biopsy
;
Biopsy, Large-Core Needle
;
Catheter Ablation
;
Follow-Up Studies
;
Humans
;
Hyalin
;
Methods
;
Pathology
;
Retrospective Studies
;
Thyroid Gland
;
Thyroid Nodule
;
Ultrasonography
3.Borderline Thyroid Tumors: a Surgeon's Perspectives
International Journal of Thyroidology 2019;12(1):15-18
Borderline thyroid tumors are composed of hyalinizing trabecular tumor (HTT), well differentiated tumor of uncertain malignant potential (WDT-UMP), follicular tumor of uncertain malignant potential (FT-UMP) and non-invasive follicular tumor with papillary like nuclear feature (NIFTP) by World Health Organization (WHO) definition. They have different pathological feature from each other. However, it is difficult to diagnose with diagnostic imaging, fine needle aspiration (FNA) or core biopsy preoperatively. Thus, the diagnosis is usually made after diagnostic lobectomy. Main surgical concerns about borderline tumor are not performing total thyroidectomy because of relatively indolent nature of these tumors. Unfortunately, some of these tumors can be diagnosed as malignant tumor preoperatively. The other surgical concern is performing completion thyroidectomy or not after diagnostic lobectomy. Decision making is difficult even though it is generally considered that lobectomy alone is enough. In this article, we will discuss clinical features of borderline malignant tumors and surgical strategy for these tumors.
Biopsy
;
Biopsy, Fine-Needle
;
Decision Making
;
Diagnosis
;
Diagnostic Imaging
;
Hyalin
;
Thyroid Gland
;
Thyroidectomy
;
World Health Organization
4.Understanding Neoplasm of Uncertain or Unknown Behavior of the Thyroid in Korean Clinical Practice
International Journal of Thyroidology 2019;12(1):1-8
Thyroid tumors include a heterogeneous group of entities with variable clinical behavior and histology, mostly classified as benign or malignant. Neoplasm of uncertain or unknown behavior in thyroid gland was newly adopted by the 2017 edition of World Health Organization (WHO) classification of endocrine organs. The borderline thyroid tumors include a hyalinizing trabecular tumor and three encapsulated follicular-patterned thyroid tumors (follicular tumor of uncertain malignant potential, well-differentiated tumor of uncertain malignant potential, and non-invasive follicular thyroid neoplasm with papillary-like nuclear features). This review summarizes the changes in the 2017 WHO classification of thyroid tumors, highlights their implications for clinical practice in Korea, and briefly discusses National Health Insurance system, cancer insurance policies, and their associated benefits in Korea.
Classification
;
Hyalin
;
Insurance
;
Korea
;
National Health Programs
;
Thyroid Gland
;
Thyroid Neoplasms
;
World Health Organization
5.History of Pulmonary Surfactant Replacement Therapy for Neonatal Respiratory Distress Syndrome in Korea
Chong Woo BAE ; Chae Young KIM ; Sung Hoon CHUNG ; Yong Sung CHOI
Journal of Korean Medical Science 2019;34(25):e175-
Neonatal respiratory distress syndrome (RDS) is a disease that is unique to newborn infants. It is caused by a deficiency of pulmonary surfactant (PS), which is usually ready to be activated around the perinatal period. Until RDS was more clearly understood, it was not known why premature infants died from respiratory failure, although pathology revealed hyaline membranes in the alveoli. Surprisingly, the era of PS replacement therapy began only relatively recently. The first clinical trial investigating neonatal RDS was conducted in 1980. Since then, newborn survival has improved dramatically, which has led to significant advances in the field of neonatology. The present comprehensive review addresses PS, from its discovery to the application of artificial PS in newborns with RDS. It also reviews the history of PS in Korea, including its introduction, various commercial products, present and past research, newborn registries, and health insurance issues. Finally, it describes the inception of the Korean Society of Neonatology and future directions of research and treatment.
History of Medicine
;
Humans
;
Hyalin
;
Infant, Newborn
;
Infant, Premature
;
Insurance, Health
;
Korea
;
Membranes
;
Neonatology
;
Pathology
;
Pulmonary Surfactants
;
Registries
;
Respiratory Distress Syndrome, Newborn
;
Respiratory Insufficiency
6.Repair of Osteochondral Defects in Rabbit Knee Using Menstrual Blood Stem Cells Encapsulated in Fibrin Glue: A Good Stem Cell Candidate for the Treatment of Osteochondral Defects
Manijeh KHANMOHAMMADI ; Hannaneh GOLSHAHI ; Zahra SAFFARIAN ; Samaneh MONTAZERI ; Somaye KHORASANI ; Somaieh KAZEMNEJAD
Tissue Engineering and Regenerative Medicine 2019;16(3):311-324
BACKGROUND: In recent years, researchers discovered that menstrual blood-derived stem cells (MenSCs) have the potential to differentiate into a wide range of tissues including the chondrogenic lineage. In this study, we aimed to investigate the effect of MenSCs encapsulated in fibrin glue (FG) on healing of osteochondral defect in rabbit model. METHODS: We examined the effectiveness of MenSCs encapsulated in FG in comparison with FG alone in the repair of osteochondral defect (OCD) lesions of rabbit knees after 12 and 24 weeks. RESULTS: Macroscopical evaluation revealed that the effectiveness of MenSCs incorporation with FG is much higher than FG alone in repair of OCD defects. Indeed, histopathological evaluation of FG + MenSCs group at 12 weeks post-transplantation demonstrated that defects were filled with hyaline cartilage-like tissue with proper integration, high content of glycosaminoglycan and the existence of collagen fibers especially collagen type II, as well as by passing time (24 weeks post-transplantation), the most regenerated tissue in FG + MenSCs group was similar to hyaline cartilage with relatively good infill and integration. As the same with the result of 12 weeks post-implantation, the total point of microscopical examination in FG + MenSCs group was higher than other experimental groups, however, no significant difference was detected between groups at 24 weeks (p>0.05). CONCLUSION: In summary, MenSCs as unique stem cell population, is suitable for in vivo repair of OCD defects and promising for the future clinical application.
Collagen
;
Collagen Type II
;
Fibrin Tissue Adhesive
;
Fibrin
;
Hyalin
;
Hyaline Cartilage
;
Knee
;
Stem Cells
7.A Case of Hyaline Fibromatosis Syndrome with a New Variant of Genetic Mutation in ANTXR2 Gene
Chan Seong PARK ; Jongeun LEE ; Hyun Jeong BYUN ; Youngkyoung LIM ; Ji Hye PARK ; Jong Hee LEE ; Dong Youn LEE ; Joo Heung LEE ; Jun Mo YANG ; Jee Hun LEE ; So Young YOO
Annals of Dermatology 2019;31(Suppl):S12-S13
No abstract available.
Hyalin
;
Hyalinosis, Systemic
8.Hyalinizing Cholecystitis and Associated Carcinoma: A Case Report
Youngjin KANG ; Yang Seok CHAE ; Chul Hwan KIM ; Youngseok LEE ; Dong Sik KIM ; Young Dong YU ; Joo Young KIM
Journal of Pathology and Translational Medicine 2018;52(1):64-66
No abstract available.
Cholecystitis
;
Hyalin
9.Hyalinizing Trabecular Tumor of the Thyroid Gland, a Diagnostic Challenge in Fine-Needle Aspiration Cytology: Case Report
Ye Young RHEE ; Hong Kyu JUNG ; Se Hoon KIM ; Soo Hee KIM
Journal of Pathology and Translational Medicine 2018;52(4):252-256
Hyalinizing trabecular tumor (HTT) is a rare thyroid tumor with low to minimal malignant potential. HTT is often misinterpreted as other thyroid tumors, including papillary thyroid carcinoma (PTC) and medullary thyroid carcinoma (MTC), on fine-needle aspiration (FNA) cytology, because of its overlapping cytologic features, such as nuclear grooves and intranulcear pseudoinclusions. Although cytopathologists cannot definitely conclude HTT by FNA cytology, suspicion of HTT is necessary to avoid misdiagnosing HTT as PTC or MTC and to avoid unnecessary aggressive treatment. Here, we report a case of HTT with novel cytologic features in CellPrep liquid based cytology that was diagnosed as suspicious for papillary carcinoma by FNA and finally diagnosed as HTT in the surgical specimen.
Biopsy, Fine-Needle
;
Carcinoma, Papillary
;
Hyalin
;
Thyroid Gland
;
Thyroid Neoplasms
10.Microcystic Stromal Tumor of Testicle: First Case Report and Literature Review.
Pengcheng ZHU ; Yaqi DUAN ; Qilin AO ; Guoping WANG
Cancer Research and Treatment 2018;50(4):1452-1457
Microcystic stromal tumor (MCST) is a rare subtype of sex cord-stromal neoplasm. Tumors from all 31 previously reported cases were located in the ovary. Herein, we present a unique case of a right-side testicular tumor in a 33-year-old Chinese male. The tumor is composed of predominantly lobulated cellular nodules separated by hyalinized fibrous stroma and they expressed CD10, β-catenin (nuclear), and cyclin D1. Molecular analysis identified a point mutation (c.110C>G) in exon 3 of CTNNB1. The histopathological features, immunohistochemistry profiles, and molecular analysis of this tumor were consistent with MCST of the ovary. Therefore, a diagnosis of MCST of the right testicle was determined. To the best of our knowledge, this is the first case of MCST occurring in the testicles. The study may provide new insights to the tumor biology of MCST and a better understanding of this rare entity.
Adult
;
Asian Continental Ancestry Group
;
Biology
;
Cyclin D1
;
Diagnosis
;
Exons
;
Female
;
Humans
;
Hyalin
;
Immunohistochemistry
;
Male
;
Ovary
;
Point Mutation
;
Testis*

Result Analysis
Print
Save
E-mail